Plant Based Vaccines Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)

The Plant based vaccines market size is projected to reach US$ 3.96 billion by 2031 from US$ 1.44 billion in 2023. The market is expected to register a CAGR of 13.5% during 2023–2031. Increasing product launches and product approvals are likely to remain key trends in the market.

Plant Based Vaccines Market Analysis

Increasing number of research and development activities in plant-based vaccines leads to product approval and launches along with growing prevalence of infectious disease is expected to drive the growth of plant-based vaccines market. Moreover, increasing fundings and technological advancement in research activities is expected to contribute the market growth. Moreover, advancement in product of plant-based vaccines such as Gene transfer by agrobacterium and transformation via a genetically engineered plant virus are two typical approaches for producing efficient vaccines is expected to create ample opportunities in the coming years.

Plant Based Vaccines Market Overview

Increasing number of research and development activities in plant-based vaccines leads to product approval and launches along with growing prevalence of infectious disease is expected to drive the growth of plant-based vaccines market. Moreover, North America accounts for the major market share in 2023 owing to the rising number of product launch, product approval along with the spur in research and development activities. Europe is second largest region after North America and Asia Pacific is expected to register significant growth rate owing to the rising development of research studies and the increasing prevalence of infectious diseases that have skyrocketed the need for the plant-based vaccines market. The countries such as Australia, India, and South Korea are estimated to serve various growth opportunities due to the rising development in the pharmaceutical sector are the factors contributing to the market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Plant Based Vaccines Market: Strategic Insights

Market Size Value in	US$ 1,143.72 million in 2021
Market Size Value by	US$ 2,672.05 million by 2028
Growth rate	CAGR of 12.9 % from 2021 to 2028
Forecast Period	2021-2028
Base Year	2021

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Plant Based Vaccines Market Drivers and Opportunities

Increasing Prevalence of Infectious Diseases to Favor Market

The rising prevalence of infectious diseases such as COVID-19, influenza, the common cold, tuberculosis (TB), hepatitis A and B is expected to flourish the demand for plant-based vaccines during the forecast period. On December 31, 2019, a COVID-19 case was first detected in Wuhan, China. On March 11, 2020, the World Health Organization proclaimed COVID-19 a pandemic. COVID-19's rapid proliferation is posing a challenge to the healthcare systems around the world. Hospitals and intensive care units (ICUs) in many nations are overburdened or on the verge of collapsing. As a result, the most efficient use of healthcare resources is required. With limited access to breathing equipment, skilled critical care employees, or protected patient monitoring systems, healthcare providers are compelled to treat extremely ill patients. The endeavor to keep COVID-19 patients from deteriorating and being admitted to the ICU is enormous. To slow the spread of the SARS-CoV-2 virus and prevent future outbreaks, the need for new diagnostics, treatments, and vaccinations is high.

Advancement in Production of Plant-Based Vaccines

Various approaches are used to integrate the desired genes encoding the antigen protein for a given illness into the genome of plant tissues in plant-based vaccination technology. Gene transfer by agrobacterium and transformation via a genetically engineered plant virus are two typical approaches for producing efficient vaccines. However, as science and technology have progressed, new approaches have been created to improve the efficiency of older technologies, including biolistic, electroporation, agroinfiltration, sonication, and polyethylene glycol treatment. When microbial genes are incorporated into the plant genome, they are translated into target pathogen protein antigens without harming the plant or losing their immunogenicity. The systemic and mucosal immune responses are involved in initiating host immunity against the infection. Some vaccinations, such as cholera, Lyme disease, anthrax, tetanus, plague, rotavirus, and canine parvovirus, are made using direct bombardment or biolistic methods. Tuberculosis, dengue, avian flu, and Ebola vaccines have been developed using indirect methods or Agrobacterium-mediated gene transfer.

Plant Based Vaccines Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Plant based vaccines market analysis are vaccine type, source, and application.

• Based on vaccine type, the Plant based vaccines market is segmented bacterial vaccines, viral vaccines, parasite vaccines, plant-derived virus-like particles (VLPS), and others. The bacterial vaccines segment held the largest market share in 2023.
• By source, the market is segmented into tobacco plant, maize, potato, and others. The tobacco plant segment held the largest share of the market in 2023.
• In terms of application, the market is classified into influenza, zika virus, Ebola virus, poultry disease, Covid-19, and others. The influenza segment held a significant share of the market in 2023.

Plant Based Vaccines Market Share Analysis by Geography

The geographic scope of the Plant based vaccines market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market owing to the rising number of product launch along with the spur in research and development activities. However, during the forecast period the market is likely to get restrained by the factors such as challenges associated with the product approval, and the contamination and environmental risks for manufacturing plant-based vaccines. The US is the largest market for plant-based vaccines at a global level. The market's growth is attributed to the enormous number of R&D activities in the field of plant-based vaccines carried out in the country. The rising prevalence of infectious diseases in this region is anticipated to flourish the demand for plant-based vaccines. Infections such as viral hepatitis, influenza, and tuberculosis (TB) continue to be among the major causes of disease and death in the United States, resulting in significant spending on infection-related complications. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Plant Based Vaccines Market Report Scope

Plant Based Vaccines Market News and Recent Developments

The Plant based vaccines market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Plant based vaccines market are listed below:

• Medicago and GlaxoSmithKline (GSK) declared that Health Canada has granted approval for COVIFENZ, COVID-19 vaccine, (plant-based virus-like particles [VLP], recombinant, adjuvanted). This vaccine is indicated for active immunization to prevent coronavirus disease 2019 (COVID‑19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in individuals 18 to 64 years of age. (Source: GlaxoSmithKline, Press Release, February 2022)
• CEPI providing LenioBio with funding of up to US$2 million to provide preclinical proof-of-concept that a commercially available, plant-based, and cell-free technology can produce proteins to be used in vaccine trials for epidemic and pandemic threats in 20-40 days. Using LenioBio’s ALiCE technology, the ambition is to reduce the time required to manufacture vaccine proteins with “more traditional methods” like cell cultures. (Source: CEPI, Newsletter, May 2024)

Plant Based Vaccines Market Report Coverage and Deliverables

The “Plant Based Vaccines Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Plant based vaccines market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Plant based vaccines market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Plant based vaccines market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Plant based vaccines market
• Detailed company profiles